BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18311478)

  • 1. Mechanistic analysis of chemical permeation enhancers for oral drug delivery.
    Whitehead K; Mitragotri S
    Pharm Res; 2008 Jun; 25(6):1412-9. PubMed ID: 18311478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
    Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
    Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives.
    Muheem A; Shakeel F; Jahangir MA; Anwar M; Mallick N; Jain GK; Warsi MH; Ahmad FJ
    Saudi Pharm J; 2016 Jul; 24(4):413-28. PubMed ID: 27330372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal permeation enhancers for oral peptide delivery.
    Maher S; Mrsny RJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
    Gupta V; Hwang BH; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C
    Twarog C; Fattah S; Heade J; Maher S; Fattal E; Brayden DJ
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.
    Halberg IB; Lyby K; Wassermann K; Heise T; Zijlstra E; Plum-Mörschel L
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):179-188. PubMed ID: 30679095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist.
    Buckley ST; Bækdal TA; Vegge A; Maarbjerg SJ; Pyke C; Ahnfelt-Rønne J; Madsen KG; Schéele SG; Alanentalo T; Kirk RK; Pedersen BL; Skyggebjerg RB; Benie AJ; Strauss HM; Wahlund PO; Bjerregaard S; Farkas E; Fekete C; Søndergaard FL; Borregaard J; Hartoft-Nielsen ML; Knudsen LB
    Sci Transl Med; 2018 Nov; 10(467):. PubMed ID: 30429357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Insulin Delivery in a Physiologic Context: Review.
    Arbit E; Kidron M
    J Diabetes Sci Technol; 2017 Jul; 11(4):825-832. PubMed ID: 28654313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term daily oral administration of intestinal permeation enhancers is safe and effective in mice.
    Fein KC; Gleeson JP; Cochran K; Lamson NG; Doerfler R; Melamed JR; Whitehead KA
    Bioeng Transl Med; 2023 Jan; 8(1):e10342. PubMed ID: 36684095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization technique of gases permeation properties in polymers: H
    Jung JK; Lee JH; Jang JS; Chung NK; Park CY; Baek UB; Nahm SH
    Sci Rep; 2022 Feb; 12(1):3328. PubMed ID: 35228634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.
    Pedro SN; R Freire CS; Silvestre AJD; Freire MG
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in oral peptide therapeutics.
    Drucker DJ
    Nat Rev Drug Discov; 2020 Apr; 19(4):277-289. PubMed ID: 31848464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments.
    Lamson NG; Ball RL; Fein KC; Whitehead KA
    Pharm Res; 2019 Oct; 36(12):172. PubMed ID: 31659456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive delivery strategies for biologics.
    Anselmo AC; Gokarn Y; Mitragotri S
    Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Sodium
    Li Y; Yang D; Zhu C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionic liquids for addressing unmet needs in healthcare.
    Agatemor C; Ibsen KN; Tanner EEL; Mitragotri S
    Bioeng Transl Med; 2018 Jan; 3(1):7-25. PubMed ID: 29376130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.
    Bzik VA; Brayden DJ
    Pharm Res; 2016 Oct; 33(10):2506-16. PubMed ID: 27387171
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.